Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

312 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sodium-glucose cotransporter-2 inhibition in a CKD patient with severe heart failure treated by high-dose diuretics and peritoneal ultrafiltration: lesson for the clinical nephrologist.
Borrelli S, Garofalo C, Liberti ME, Ruotolo C, Capozzi F, Yavorskiy P, De Nicola L. Borrelli S, et al. Among authors: de nicola l. J Nephrol. 2024 Jan;37(1):199-201. doi: 10.1007/s40620-023-01766-x. Epub 2023 Sep 14. J Nephrol. 2024. PMID: 37707693 No abstract available.
Prognosis of CKD patients receiving outpatient nephrology care in Italy.
De Nicola L, Chiodini P, Zoccali C, Borrelli S, Cianciaruso B, Di Iorio B, Santoro D, Giancaspro V, Abaterusso C, Gallo C, Conte G, Minutolo R; SIN-TABLE CKD Study Group. De Nicola L, et al. Clin J Am Soc Nephrol. 2011 Oct;6(10):2421-8. doi: 10.2215/CJN.01180211. Epub 2011 Aug 4. Clin J Am Soc Nephrol. 2011. PMID: 21817127 Free PMC article.
Sex difference in cardiovascular risk in patients with chronic kidney disease: pooled analysis of four cohort studies.
Borrelli S, Garofalo C, Gabbai FB, Liberti ME, Chiodini P, Simeon V, De Nicola L, Minutolo R; Collaborative Study Group on the Conservative Treatment of CKD of the Italian Society of Nephrology. Borrelli S, et al. Among authors: de nicola l. Nephrol Dial Transplant. 2023 Feb 16:gfad036. doi: 10.1093/ndt/gfad036. Online ahead of print. Nephrol Dial Transplant. 2023. PMID: 36796825
Hyperkalemia in CKD: an overview of available therapeutic strategies.
Costa D, Patella G, Provenzano M, Ielapi N, Faga T, Zicarelli M, Arturi F, Coppolino G, Bolignano D, De Sarro G, Bracale UM, De Nicola L, Chiodini P, Serra R, Andreucci M. Costa D, et al. Among authors: de nicola l, de sarro g. Front Med (Lausanne). 2023 Jul 31;10:1178140. doi: 10.3389/fmed.2023.1178140. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37583425 Free PMC article. Review.
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial.
Sasso FC, Simeon V, Galiero R, Caturano A, De Nicola L, Chiodini P, Rinaldi L, Salvatore T, Lettieri M, Nevola R, Sardu C, Docimo G, Loffredo G, Marfella R, Adinolfi LE, Minutolo R; NID-2 study group Investigators. Sasso FC, et al. Among authors: de nicola l. Cardiovasc Diabetol. 2022 Nov 7;21(1):235. doi: 10.1186/s12933-022-01674-7. Cardiovasc Diabetol. 2022. PMID: 36344978 Free PMC article. Clinical Trial.
Glomerular and tubular effects of dapagliflozin, eplerenone and their combination in patients with chronic kidney disease: A post-hoc analysis of the ROTATE-3 study.
Lieverse TTGF, Puchades MJ, Mulder UDJ, Provenzano M, Krenning G, Jongs N, Wink SE, Slart RHJA, Andreucci M, D'Marco L, De Nicola L, Gorriz JL, Heerspink HJL. Lieverse TTGF, et al. Among authors: de nicola l. Diabetes Obes Metab. 2024 Feb;26(2):576-582. doi: 10.1111/dom.15346. Epub 2023 Nov 5. Diabetes Obes Metab. 2024. PMID: 37926904 Clinical Trial.
Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies.
Barratt J, Dellanna F, Portoles J, Choukroun G, De Nicola L, Young J, Dimković N, Reusch M. Barratt J, et al. Among authors: de nicola l. Adv Ther. 2023 Apr;40(4):1546-1559. doi: 10.1007/s12325-023-02433-0. Epub 2023 Feb 7. Adv Ther. 2023. PMID: 36749544 Free PMC article. Clinical Trial.
Translating the efficacy of dapagliflozin in chronic kidney disease to lower healthcare resource utilization and costs: a medical care cost offset analysis.
McEwan P, Hafner M, Jha V, Correa-Rotter R, Chernin G, De Nicola L, Villanueva R, Wheeler DC, Barone S, Nolan S, Garcia Sanchez JJ. McEwan P, et al. Among authors: de nicola l. J Med Econ. 2023 Jan-Dec;26(1):1407-1416. doi: 10.1080/13696998.2023.2264715. Epub 2023 Oct 31. J Med Econ. 2023. PMID: 37807895 Free article. Review.
Renin-Angiotensin-Aldosterone System: From History to Practice of a Secular Topic.
Ksiazek SH, Hu L, Andò S, Pirklbauer M, Säemann MD, Ruotolo C, Zaza G, La Manna G, De Nicola L, Mayer G, Provenzano M. Ksiazek SH, et al. Among authors: de nicola l. Int J Mol Sci. 2024 Apr 4;25(7):4035. doi: 10.3390/ijms25074035. Int J Mol Sci. 2024. PMID: 38612843 Free PMC article. Review.
312 results